At this year’s CPHI Frankfurt, Olon invites partners and visitors to explore how its integrated expertise is driving innovation across the life sciences industry. Combining deep capabilities in chemical synthesis, high-potency (HPAPI) development, bioconjugation and antibody-drug conjugate (ADC) technologies, and fermentation, Olon delivers true end-to-end support, from early development through to commercial manufacturing. Building on […]
Post Type Archives: News
Hovione Completes Initial $100M Investment Cycle to Expand U.S. Operations at New Jersey Manufacturing Campus
Hovione a fully-integrated global CDMO, today announced the completion of an initial multi-million-dollar investment cycle to expand its manufacturing campus in East Windsor, New Jersey. Upon completion, this world-class campus will cover more than 200,000 square feet, integrating the latest technologies within sustainably designed facilities. The initiative advances Hovione’s long-term strategy to grow its U.S. operations […]
Kindeva announces the appointment of David Stevens as President
Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, announced the promotion of David Stevens, Chief Operating and Commercial Officer, to the newly created role of President. In this capacity, David will lead Kindeva’s global operations. With over 20 years of experience in the CDMO industry, David has led high-performing teams […]
Sunresin Announces USD 160 million Investment to Build State-of-the-Art Life Sciences Industrial Park in Pucheng
Sunresin’s new facility, with a total investment of approximately USD 160 million, will cover 18 hectares and significantly increase the production capacity of chromatography resins and advanced separation materials, thereby reinforcing the company’s long-term commitment to the life sciences sector. Sunresin New Materials Co., Ltd. has announced plans to invest USD 160 million in the […]
New Positioning Strengthens Commitment to End-to-End Biopharma Development Solutions
Syner-G has unveiled a new brand and service delivery model to accelerate biopharmaceutical product development and commercialization. Syner-G is a first-of-its-kind Strategic Development and Delivery Partner™ that brings together scientists, engineers, regulatory and quality experts, and business strategists—working as one holistic team—to deliver the integrated solutions biopharmaceutical companies need across the development lifecycle. “At Syner-G, […]
IMCD showcases greener, smarter, patient-centric solutions at CPHI Frankfurt 2025
IMCD Group, a global leading partner for the distribution and formulation of speciality chemicals and ingredients, will exhibit at CPHI Frankfurt 2025 from 28 to 30 October, where its experts will unveil a portfolio of greener, smarter, patient-centric solutions designed to meet the evolving demands of the pharmaceutical industry. At this year’s event, IMCD will […]
Orion and Abzena Announce Exclusive Commercial License for Abzena’s Antibody
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced that Orion has obtained an exclusive focused commercial license to one of Abzena’s monoclonal antibodies (mAbs) that targets a cancer of high clinical unmet need. The antibody will strengthen Orion’s broad oncology-focused drug Research and Development (R&D) pipeline. The antibody was designed and […]
ProImmune Expands into New 18,000 sq ft Global Headquarters Enabling Major Expansion in Immunology and Life Science Innovation
ProImmune Ltd, a global leader in life science reagents and services, announced the opening of its new global headquarters building at Oasis Park, Oxford, enabling significant expansion of its operations and capacity to serve its global client base. Located within Oxford’s renowned bioscience and innovation ecosystem, the 70,000 sq ft Oasis Park is already home […]
SK pharmteco Boosts Domestic Peptide Scale-Up with Investment in California Facility
SK pharmteco, a global contract development and manufacturing organization (CDMO), announced today a $6.1 million investment in its Rancho Cordova facility to expand and equip a new lab and CGMP-kilo-scale facility for Solid-Phase Peptide Synthesis (SPPS) and purification. This expansion, combined with SK pharmteco’s industry-leading chromatography expertise and existing development and manufacturing capabilities in the […]
Sunresin welcomes Hans Johansson as General Manager of Sunresin EU
Following the recent creation of Sunresin EU, Sunresin New Materials Co., Ltd. is pleased to announce the incorporation of Hans Johansson as General Manager of its new European subsidiary, based in Uppsala, Sweden. Hans Johansson brings over 35 years of experience in the chromatography and bioprocessing industry, with a distinguished career that began at Uppsala University and […]